Endo LP
company.status.inactiveCIK 2008861fmd_0TSNQ85X9R8XY6AKWTGWZ7XWQ9Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2023 to Mar 31, 2025, 8 periods
Latest annual · FY2024
Millions- Total revenues
- 1,178
- Gross profit
- (6)
- Net income
- (731)
- Free cash flow
- 76
Latest quarter · Q1 FY2025
Millions- Total revenues
- 393
- Gross profit
- 97
- Net income
- (129)
- Free cash flow
- (12)
Endo LP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | Change | Source | |
|---|---|---|---|---|
| Revenue | $1.2 billion | 10-K 2025-03-13 · proof | ||
| Gross profit | -$6.3 million | 10-K 2025-03-13 · proof | ||
| Net income | -$730.9 million | 10-K 2025-03-13 · proof | ||
| Cash from operating activities | $113.4 million | 10-K 2025-03-13 · proof | ||
| Free cash flow | $76.4 million | 10-K 2025-03-13 · proof | ||
| Total assets | $4.4 billion | 10-K 2025-03-13 · proof | ||
| Total liabilities | $3.1 billion | 10-K 2025-03-13 · proof | ||
| Cash and cash equivalents | $387.2 million | 10-K 2025-03-13 · proof | ||
| Total debt | $2.4 billion | 10-K 2025-03-13 · proof |
- What was Endo LP's revenue in fiscal 2024?
- Endo LP reported revenue of $1.2 billion for fiscal 2024 (the year ended Dec 31, 2024). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Endo LP's gross profit in fiscal 2024?
- Endo LP reported gross profit of -$6.3 million for fiscal 2024 (the year ended Dec 31, 2024). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Endo LP's net income in fiscal 2024?
- Endo LP reported net income of -$730.9 million for fiscal 2024 (the year ended Dec 31, 2024). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Endo LP's cash from operating activities in fiscal 2024?
- Endo LP reported cash from operating activities of $113.4 million for fiscal 2024 (the year ended Dec 31, 2024). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Endo LP's free cash flow in fiscal 2024?
- Endo LP reported free cash flow of $76.4 million for fiscal 2024 (the year ended Dec 31, 2024). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Endo LP's total assets?
- As of Dec 31, 2024, Endo LP reported total assets of $4.4 billion. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Endo LP's total liabilities?
- As of Dec 31, 2024, Endo LP reported total liabilities of $3.1 billion. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Endo LP's cash and cash equivalents?
- As of Dec 31, 2024, Endo LP reported cash and cash equivalents of $387.2 million. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What is Endo LP's total debt?
- As of Dec 31, 2024, Endo LP reported total debt of $2.4 billion. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:2008861&period_type=annual&limit=5"Information only, not investment advice.